Final 5-year updated results from a phase 3 study (HELIOS) of ibrutinib plus bendamustine and rituximab (BR) in patients with relapsed/refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)


Fraser G., Chanan-Khan A., Demirkan F., Silva R. S., Grosicki S., Janssens A., ...More

LEUKEMIA & LYMPHOMA, vol.61, pp.106-108, 2020 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 61
  • Publication Date: 2020
  • Journal Name: LEUKEMIA & LYMPHOMA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.106-108
  • Dokuz Eylül University Affiliated: Yes